Peripheral Nerve Stimulators Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

The prevalence of neurologic disorders continues to rise, affecting approximately 50 million Americans annually, according to data from the National Institute of Neurological Disorders and Stroke. Neuropathic pain, a common issue in industrialized nations, impacts 40%-60% of the geriatric population and adults worldwide. As a result, the demand for peripheral nerve stimulators, utilized in treating various diseases such as complex regional pain syndrome, low back pain, neck pain, and painful nerve injuries, is on the rise.

Rising Cases of Nerve Injuries and Aging Population Fuel Market Growth

The peripheral nerve stimulator market is expected to witness significant growth due to an increasing number of nerve injury cases and a growing aging population, coupled with the rise in obesity rates. These devices play a crucial role in anesthesia procedures and managing severe neuropathic pain. Studies, such as one conducted by St. Jude Medical, demonstrate the effectiveness of peripheral nerve stimulators, with 65% of patients reporting excellent or good headache pain relief.

Technological Advancements Drive Market Expansion

Advancements in pain management technology are expected to further propel market growth. Manufacturers are continuously enhancing product capabilities through technological innovations, leading to increased adoption of peripheral nerve stimulators. Unlike traditional medication, stimulation therapy targets pain specifically, minimizing the risk of systemic side effects such as constipation and sleepiness.

Competitive Analysis and Strategic Initiatives

The peripheral nerve stimulators market features key players such as Stimwave LLC, NeuroSigma, Inc., and Medtronic, among others, adopting strategies like mergers, acquisitions, and product innovation to gain market share. These companies are investing in new facilities to enhance productivity and meet the rising demand for peripheral nerve stimulators.

The Key companies functioning in market are:

Stimwave LLC.
SUNMED INC.
Vygon SA
Boston Scientific Corporation
Medline Industries, In
Enteromedics
NeuroMetrix, Inc.
SPR Therapeutics LLC
ElectroCore, Inc.
NeuroSigma, Inc
Others.

Market Segmentation

The market is scrutinized and segmented to answer specific questions of the industry stakeholders. A wide visional assessment from every critical perspective of the market. The report offers a comprehensive taxonomy of peripheral nerve stimulators market based on product type and end users.

Based on product type, the peripheral nerve stimulators market is segmented into transcutaneous and implantable. Based on end users, the peripheral nerve stimulators market is segmented into hospitals and outpatient centers. The peripheral nerve stimulators market has been analyzed across regions of North America, Latin America, Europe, Asia Pacific Excluding Japan, Japan and MEA.

1. Executive Summary

1.1. Global Peripheral Nerve Stimulators Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

3.1. Global Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Transcutaneous
  - 3.1.1.2. Implantable
3.2. Global Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Hospitals
  - 3.2.1.2. Outpatient Center
  - 3.2.1.3. Specialty Clinics
3.3. Global Peripheral Nerve Stimulators Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. North America
  - 3.3.1.2. Europe
  - 3.3.1.3. Asia Pacific
  - 3.3.1.4. Latin America
  - 3.3.1.5. Middle East & Africa

4. North America Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

4.1. North America Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Transcutaneous
  - 4.1.1.2. Implantable
4.2. North America Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Hospitals
  - 4.2.1.2. Outpatient Center
  - 4.2.1.3. Specialty Clinics
4.3. North America Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. U.S. Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.2. U.S. Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.3.1.3. Canada Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.3.1.4. Canada Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
- 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

5.1. Europe Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Transcutaneous
  - 5.1.1.2. Implantable
5.2. Europe Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Hospitals
  - 5.2.1.2. Outpatient Center
  - 5.2.1.3. Specialty Clinics
5.3. Europe Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Germany Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.2. Germany Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.3. U.K. Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.4. U.K. Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.5. France Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.6. France Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.7. Italy Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.8. Italy Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.9. Turkey Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.10. Turkey Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.11. Russia Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.12. Russia Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.3.1.13. Rest of Europe Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.3.1.14. Rest of Europe Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
- 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

6.1. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Transcutaneous
  - 6.1.1.2. Implantable
6.2. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Hospitals
  - 6.2.1.2. Outpatient Center
  - 6.2.1.3. Specialty Clinics
6.3. Asia Pacific Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. China Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.2. China Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.3. Japan Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.4. Japan Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.5. South Korea Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.6. South Korea Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.7. India Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.8. India Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.9. Southeast Asia Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.10. Southeast Asia Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.3.1.11. Rest of Asia Pacific Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.3.1.12. Rest of Asia Pacific Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
- 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

7.1. Latin America Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Transcutaneous
  - 7.1.1.2. Implantable
7.2. Latin America Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Hospitals
  - 7.2.1.2. Outpatient Center
  - 7.2.1.3. Specialty Clinics
7.3. Latin America Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Brazil Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.2. Brazil Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.3. Mexico Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.4. Mexico Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.5. Argentina Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.6. Argentina Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.3.1.7. Rest of Latin America Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.3.1.8. Rest of Latin America Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
- 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, 2018 - 2031

8.1. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Transcutaneous
  - 8.1.1.2. Implantable
8.2. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Hospitals
  - 8.2.1.2. Outpatient Center
  - 8.2.1.3. Specialty Clinics
8.3. Middle East & Africa Peripheral Nerve Stimulators Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. GCC Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.2. GCC Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.3. South Africa Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.4. South Africa Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.5. Egypt Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.6. Egypt Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.7. Nigeria Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.8. Nigeria Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.9. Nigeria Peripheral Nerve Stimulators Market End User, Value (US$ Bn), 2018 - 2031
  - 8.3.1.10. Rest of Middle East & Africa Peripheral Nerve Stimulators Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.3.1.11. Rest of Middle East & Africa Peripheral Nerve Stimulators Market by End User, Value (US$ Bn), 2018 - 2031
- 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Stimwave LLC.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. SUNMED INC.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Vygon SA
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Boston Scientific Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Medline Industries, In
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Enteromedics
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. NeuroMetrix, Inc.
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. SPR Therapeutics LLC
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. ElectroCore, Inc.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Type Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. NeuroSigma, Inc
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Type Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations